Literature DB >> 23261990

The molecular mystique of tetrodotoxin.

Edward G Moczydlowski1.   

Abstract

In many respects tetrodotoxin (TTX) is the quintessential natural toxin. It is unequivocally toxic to mammals with LD(50) values for mice in the range of 10 μg/kg (intraperitoneal), 16 μg/kg (subcutaneous), and 332 μg/kg (oral) (Kao, 1966). Its biothreat status is recognized by its listing as a "Select Agent" by the US Department of Health and Human Services which includes regulated agents "determined to have the potential to pose a severe threat to both human and animal health" (http://www.selectagents.gov/). It has a well-defined cellular target (i.e., NaV channels) and pharmacological mode of action (i.e., block of nerve and muscle action potentials), and it is an indispensable chemical tool in neuroscience. It is widely distributed in marine and terrestrial ecosystems where it plays a role in the chemical ecology of predator-prey relationships and drives evolutionary selection of TTX-resistance (Hanifin, 2010; Williams, 2010; Zimmer and Ferrer, 2007). Lastly, TTX has acquired a certain mystique in scientific lore attributable to many fascinating aspects of its natural history and molecular interactions as presented in selected summary below. Additional information may be found in other excellent reviews (Fozzard and Lipkind, 2010; Kao, 1966; Lee and Ruben, 2008; Narahashi, 2001, 2008). Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261990     DOI: 10.1016/j.toxicon.2012.11.026

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  38 in total

Review 1.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

2.  Comment on Tamagawa and Ikeda's reinterpretation of the Goldman-Hodgkin-Katz equation : Are transmembrane potentials caused by polarization?

Authors:  Thomas Heimburg
Journal:  Eur Biophys J       Date:  2018-12       Impact factor: 1.733

3.  A Novel Single-Domain Na+-Selective Voltage-Gated Channel in Photosynthetic Eukaryotes.

Authors:  Katherine E Helliwell; Abdul Chrachri; Julie A Koester; Susan Wharam; Alison R Taylor; Glen L Wheeler; Colin Brownlee
Journal:  Plant Physiol       Date:  2020-10-01       Impact factor: 8.340

4.  Syntheses of Cyclic Guanidine-Containing Natural Products.

Authors:  Yuyong Ma; Saptarshi De; Chuo Chen
Journal:  Tetrahedron       Date:  2015-02-25       Impact factor: 2.457

5.  Is there more than one way to skin a newt? Convergent toxin resistance in snakes is not due to a common genetic mechanism.

Authors:  C R Feldman; A M Durso; C T Hanifin; M E Pfrender; P K Ducey; A N Stokes; K E Barnett; E D Brodie; E D Brodie
Journal:  Heredity (Edinb)       Date:  2015-09-16       Impact factor: 3.821

Review 6.  Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

Review 7.  Recent progress in neuroactive marine natural products.

Authors:  Ryuichi Sakai; Geoffrey T Swanson
Journal:  Nat Prod Rep       Date:  2014-01-17       Impact factor: 13.423

8.  Highly Functionalized Tricyclic Oxazinanones via Pairwise Oxidative Dearomatization and N-Hydroxycarbamate Dehydrogenation: Molecular Diversity Inspired by Tetrodotoxin.

Authors:  Steffen N Good; Robert J Sharpe; Jeffrey S Johnson
Journal:  J Am Chem Soc       Date:  2017-08-30       Impact factor: 15.419

9.  Tetrodotoxin blockade on canine cardiac L-type Ca²⁺ channels depends on pH and redox potential.

Authors:  Bence Hegyi; István Komáromi; Kornél Kistamás; Ferenc Ruzsnavszky; Krisztina Váczi; Balázs Horváth; János Magyar; Tamás Bányász; Péter P Nánási; Norbert Szentandrássy
Journal:  Mar Drugs       Date:  2013-06-14       Impact factor: 5.118

Review 10.  Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development.

Authors:  David J Newman; Gordon M Cragg
Journal:  Mar Drugs       Date:  2014-01-14       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.